Simona Sacco Selected Research

erenumab

5/2024	MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment.
11/2023	Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
11/2023	The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).
1/2023	Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis.
6/2022	European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
3/2022	Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
1/2022	Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes.
1/2022	Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index.
1/2022	Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study.
8/2021	Early outcomes of migraine after erenumab discontinuation: data from a real-life setting.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simona Sacco Research Topics

Disease

70	Migraine Disorders (Migraine) 05/2024 - 08/2008
41	Stroke (Strokes) 04/2024 - 01/2009
29	Ischemic Stroke 04/2024 - 01/2005
29	Headache (Headaches) 01/2024 - 07/2012
11	Atrial Fibrillation 12/2023 - 08/2015
9	Hemorrhage 08/2022 - 04/2015
8	Cerebral Hemorrhage 01/2024 - 07/2012
8	Pain (Aches) 08/2021 - 11/2004
4	Hypertension (High Blood Pressure) 01/2023 - 08/2008
4	Prescription Drug Overuse 01/2022 - 09/2018
3	Embolic Stroke 01/2024 - 08/2015
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 04/2015
3	Migraine with Aura (Familial Hemiplegic Migraine) 10/2017 - 04/2012
2	Heart Failure 04/2024 - 10/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2009
2	COVID-19 07/2023 - 01/2023
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 10/2021
2	Seizures (Absence Seizure) 01/2023 - 01/2014
2	Infarction (Infarctions) 08/2022 - 08/2022
2	Secondary Headache Disorders 01/2022 - 01/2021
2	Consciousness Disorders 01/2016 - 01/2015
1	Chronic Renal Insufficiency 04/2024
1	Diabetes Mellitus 04/2024
1	Hyperglycemia 04/2024
1	Dysmenorrhea (Menstrual Pain) 01/2024
1	Embolism (Embolus) 01/2024
1	Cognitive Dysfunction 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Headache Disorders (Headache Syndromes) 01/2023
1	Transient Ischemic Attack 01/2023
1	Siderosis 01/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2023
1	Hematoma 01/2023

Drug/Important Bio-Agent (IBA)

22	Monoclonal AntibodiesIBA 05/2024 - 01/2019
20	Calcitonin Gene-Related PeptideIBA 05/2024 - 01/2019
18	erenumabIBA 05/2024 - 01/2019
15	AnticoagulantsIBA 11/2023 - 02/2015
10	Type A Botulinum Toxins (Botox)FDA Link 10/2023 - 09/2018
8	Tryptamines (Triptans)IBA 03/2024 - 01/2020
8	fremanezumabIBA 03/2024 - 01/2019
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2016
6	Vitamin K FDA Link 12/2023 - 11/2017
5	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2023 - 10/2019
5	galcanezumabIBA 11/2023 - 01/2019
5	Estrogens (Estrogen)FDA Link 01/2022 - 01/2015
4	mesoglycanIBA 10/2023 - 08/2022
4	Hormones (Hormone)IBA 01/2022 - 04/2012
4	Contraceptive Agents (Contraceptives)IBA 01/2020 - 04/2012
4	sirioIBA 07/2013 - 01/2009
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 08/2022
3	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2024 - 01/2020
3	eptinezumabIBA 11/2023 - 01/2019
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024 - 01/2023
2	Tenecteplase FDA Link 01/2024 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 12/2023 - 12/2020
2	Topiramate (Topamax)FDA LinkGeneric 10/2023 - 05/2023
2	preemptIBA 10/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 07/2023 - 04/2016
2	Amitriptyline (Elavil)FDA LinkGeneric 05/2023 - 04/2023
2	Dabigatran FDA Link 01/2023 - 11/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2022 - 01/2021
2	ORALIT (ORS)IBA 08/2022 - 12/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2020
2	LipidsIBA 04/2016 - 02/2015
2	Baclofen FDA LinkGeneric 01/2015 - 01/2007
2	Antihypertensive Agents (Antihypertensives)IBA 07/2011 - 08/2008
1	MicroRNAs (MicroRNA)IBA 05/2024
1	Sodium-Glucose Transport ProteinsIBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	GalactosidasesIBA 01/2024
1	EnzymesIBA 01/2024
1	boldenone undecylenate (Equipoise)IBA 01/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2024
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 10/2023
1	FlunarizineIBA 09/2023
1	Prednisolone (Predate)FDA LinkGeneric 09/2023
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2023
1	Gabapentin (Neurontin)FDA LinkGeneric 05/2023
1	A 7 (A-7)IBA 01/2023
1	idarucizumabIBA 01/2023
1	Pioglitazone (Actos)FDA Link 01/2023
1	CI 22IBA 01/2023
1	GadoliniumIBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	dimemorfan (AT 17)IBA 01/2023

Therapy/Procedure

24	Therapeutics 03/2024 - 01/2011
16	Thrombectomy 04/2024 - 01/2020
8	Secondary Prevention 01/2024 - 09/2014
4	Contraindications 12/2023 - 09/2014
3	Contraception (Birth Control) 10/2018 - 10/2017
2	Aftercare (After-Treatment) 05/2024 - 09/2020
2	Punctures 08/2022 - 01/2020
2	Transcranial Direct Current Stimulation 01/2022 - 11/2021
2	Hormonal Contraception 01/2022 - 10/2018
2	Nerve Block (Nerve Blocks) 01/2021 - 11/2020
2	Estrogen Replacement Therapy 01/2021 - 01/2015
1	Artificial Respiration (Mechanical Ventilation) 07/2023
1	Glycemic Control 01/2023